Literature DB >> 29429126

Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Liang Chi1, Bei Gao2, Pengcheng Tu1, Chih-Wei Liu1, Jingchuan Xue1, Yunjia Lai1, Hongyu Ru3, Kun Lu4.   

Abstract

Arsenic (As) contamination in water or food is a global issue affecting hundreds of millions of people. Although As is classified as a group 1 carcinogen and is associated with multiple diseases, the individual susceptibility to As-related diseases is highly variable, such that a proportion of people exposed to As have higher risks of developing related disorders. Many factors have been found to be associated with As susceptibility. One of the main sources of the variability found in As susceptibility is the variation in the host genome, namely, polymorphisms of many genes involved in As transportation, biotransformation, oxidative stress response, and DNA repair affect the susceptibility of an individual to As toxicity and then influence the disease outcomes. In addition, lifestyles and many nutritional factors, such as folate, vitamin C, and fruit, have been found to be associated with individual susceptibility to As-related diseases. Recently, the interactions between As exposure and the gut microbiome have been of particular concern. As exposure has been shown to perturb gut microbiome composition, and the gut microbiota has been shown to also influence As metabolism, which raises the question of whether the highly diverse gut microbiota contributes to As susceptibility. Here, we review the literature and summarize the factors, such as host genetics and nutritional status, that influence As susceptibility, and we also present potential mechanisms of how the gut microbiome may influence As metabolism and its toxic effects on the host to induce variations in As susceptibility. Challenges and future directions are also discussed to emphasize the importance of characterizing the specific role of these factors in interindividual susceptibility to As-related diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29429126      PMCID: PMC6191311          DOI: 10.1007/s00335-018-9736-9

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  132 in total

Review 1.  Host-bacterial mutualism in the human intestine.

Authors:  Fredrik Bäckhed; Ruth E Ley; Justin L Sonnenburg; Daniel A Peterson; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

2.  Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations.

Authors:  Mayukh Banerjee; Jyotirmoy Sarkar; Jayanta K Das; Angshuman Mukherjee; Ajoy K Sarkar; Lakshmikanta Mondal; Ashok K Giri
Journal:  Carcinogenesis       Date:  2006-10-17       Impact factor: 4.944

3.  Polymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects.

Authors:  Nilanjana Banerjee; Sujay Nandy; James K Kearns; Apurba K Bandyopadhyay; Jayanta K Das; Papiya Majumder; Santanu Basu; Saptarshi Banerjee; Tanmoy Jyoti Sau; J Christopher States; Ashok K Giri
Journal:  Toxicol Sci       Date:  2011-02-25       Impact factor: 4.849

Review 4.  AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility.

Authors:  Ray Antonelli; Kan Shao; David J Thomas; Reeder Sams; John Cowden
Journal:  Environ Res       Date:  2014-05-08       Impact factor: 6.498

Review 5.  Biosynthesis of vitamin b2 (riboflavin).

Authors:  A Bacher; S Eberhardt; M Fischer; K Kis; G Richter
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

6.  Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.

Authors:  Mayukh Banerjee; Vanessa Marensi; Gwenaëlle Conseil; X Chris Le; Susan P C Cole; Elaine M Leslie
Journal:  Biochem Pharmacol       Date:  2016-09-19       Impact factor: 5.858

7.  A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII).

Authors:  Mayukh Banerjee; Michael W Carew; Barbara A Roggenbeck; Brayden D Whitlock; Hua Naranmandura; X Chris Le; Elaine M Leslie
Journal:  Mol Pharmacol       Date:  2014-05-28       Impact factor: 4.436

8.  Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam.

Authors:  Tetsuro Agusa; Hisato Iwata; Junko Fujihara; Takashi Kunito; Haruo Takeshita; Tu Binh Minh; Pham Thi Kim Trang; Pham Hung Viet; Shinsuke Tanabe
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-13       Impact factor: 4.219

9.  Susceptibility to arsenic-induced hyperkeratosis and oxidative stress genes myeloperoxidase and catalase.

Authors:  Habibul Ahsan; Yu Chen; Muhammad G Kibriya; Mohammad N Islam; Vesna N Slavkovich; Joseph H Graziano; Regina M Santella
Journal:  Cancer Lett       Date:  2003-11-10       Impact factor: 8.679

10.  Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.

Authors:  Jennifer L Beebe-Dimmer; Priyanka T Iyer; Jerome O Nriagu; Greg R Keele; Shilpin Mehta; Jaymie R Meliker; Ethan M Lange; Ann G Schwartz; Kimberly A Zuhlke; David Schottenfeld; Kathleen A Cooney
Journal:  Environ Health       Date:  2012-06-29       Impact factor: 5.984

View more
  8 in total

1.  Introduction to mammalian genome special issue: the combined role of genetics and environment relevant to human disease outcomes.

Authors:  Ivan Rusyn; Steven R Kleeberger; Kimberly A McAllister; John E French; Karen L Svenson
Journal:  Mamm Genome       Date:  2018-02       Impact factor: 2.957

2.  Nutrient-toxic element mixtures and the early postnatal gut microbiome in a United States longitudinal birth cohort.

Authors:  Hannah E Laue; Yuka Moroishi; Brian P Jackson; Thomas J Palys; Juliette C Madan; Margaret R Karagas
Journal:  Environ Int       Date:  2020-03-03       Impact factor: 9.621

3.  The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.

Authors:  Vicki L Sutherland; Charlene A McQueen; Donna Mendrick; Donna Gulezian; Carl Cerniglia; Steven Foley; Sam Forry; Sangeeta Khare; Xue Liang; Jose E Manautou; Donald Tweedie; Howard Young; Alexander V Alekseyenko; Frank Burns; Rod Dietert; Alan Wilson; Connie Chen
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 4.  Arsenic toxicokinetic modeling and risk analysis: Progress, needs and applications.

Authors:  Elaina M Kenyon
Journal:  Toxicology       Date:  2021-05-07       Impact factor: 4.571

Review 5.  Hallmarks of environmental insults.

Authors:  Annette Peters; Tim S Nawrot; Andrea A Baccarelli
Journal:  Cell       Date:  2021-03-02       Impact factor: 66.850

6.  Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations.

Authors:  Hisham A El-Masri; Tao Hong; Cara Henning; William Mendez; Edward E Hudgens; David J Thomas; Janice S Lee
Journal:  Environ Health Perspect       Date:  2018-07-16       Impact factor: 9.031

Review 7.  Recent Advances in Arsenic Research: Significance of Differential Susceptibility and Sustainable Strategies for Mitigation.

Authors:  Tamalika Sanyal; Pritha Bhattacharjee; Somnath Paul; Pritha Bhattacharjee
Journal:  Front Public Health       Date:  2020-10-08

8.  Association of arsenic-induced cardiovascular disease susceptibility with genetic polymorphisms.

Authors:  Mohammad Al-Forkan; Fahmida Binta Wali; Laila Khaleda; Md Jibran Alam; Rahee Hasan Chowdhury; Amit Datta; Md Zillur Rahman; Nazmul Hosain; Mohammad Fazle Maruf; Muhammad Abdul Quaium Chowdhury; N K M Mirazul Hasan; Injamamul Ismail Shawon; Rubhana Raqib
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.